← FDA ENFORCEMENT
D-0041-2027Class II
Houston Rx LLC
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Recalling firm
Houston Rx LLC
Product type
Drug
Status
Ongoing
Report date
2026-10-21
Distribution
Nationwide in the USA.
Firm state
TX
Product quantity
7 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Risk Management & CAPAReason for recall
Lack of process control
Product description
Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
Code / lot info
Lot# SER-081726-1-10, Beyond Use Date: 10/01/2026.
Other recalls SPEQ maps to Risk Management & CAPA
2026-10-21Class IICook Incorporated2026-10-21Class IIBaxter Healthcare Corporation2026-10-14Class IIQUANTUM OPS Inc2026-10-14Class IILeMaitre Vascular, Inc.
See all Risk Management & CAPA recalls →Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →